Skip to Content


In some countries, this medicine may only be approved for veterinary use.

In the US, Isoxsuprine (isoxsuprine systemic) is a member of the drug class peripheral vasodilators and is used to treat Cerebrovascular Insufficiency, Coronary Artery Disease and Raynaud's Syndrome.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Peripheral vasodilator

β-Sympathomimetic agent

Chemical Name

Benzenemetanol, 4-hydroxy-α-[1-[(1-metyl-2-phenoxyetyl)amino]etyl]-

Foreign Names

  • Isoxsuprinum (Latin)
  • Isoxsuprin (German)
  • Isoxsuprine (French)
  • Isoxsuprina (Spanish)

Generic Names

  • Isoxsuprina (OS: DCIT)
  • Isoxsuprine (OS: BAN, DCF)
  • Caa 40 (IS)
  • GR 62 (IS)
  • Isoxsuprine Hydrochloride (OS: BANM, JAN)
  • Isoxsuprine (chlorhydrate d') (PH: Ph. Eur. 8)
  • Isoxsuprine Hydrochloride (PH: BP 2016, JP XVI, USP 38)
  • Isoxsuprine hydrochloride (PH: Ph. Eur. 8)
  • Isoxsuprinhydrochlorid (PH: Ph. Eur. 8)
  • Isoxsuprini hydrochloridum (PH: Ph. Eur. 8)

Brand Names


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.